R Grid
Entrepreneur First '19London, GB · Founded 2019 · 40 employees on LinkedIn · 3 known investors
Find your way into R Grid
666 people in our graph share verified history with the R Grid team — schools, employers, funds. One of them is your warm intro.
Research Grid (R.grid) builds AI-native automation software for clinical trials, offering two products: Inclusive, a patient and community engagement and sourcing platform, and TrialEngine, a clinical trial automation system for administration, patient tracking, data management, and reporting. It serves pharmaceutical companies and clinical research teams looking to automate back-office trial workflows from pre-trial planning to trial close.
Also known as R Grid · R.grid · Research Grid
Founders & leadership
R Grid was founded in 2019 by Amber Hill.
Investors · 3
.jpeg){kind=logo}
Company profile
researched Aug 2026Research Grid, also branded R.grid, develops AI-native automation software for clinical trials, positioning its offering as an end-to-end platform covering workflows from pre-trial planning through trial close. The company describes its architecture as providing full traceability across trial stages and targets the elimination of manual back-office administration in trial operations.
The product line consists of two components. Inclusive is a patient and community engagement, sourcing and management platform intended for early trial preparation; the company states it provides access to a network of more than 99,000 patient communities covering over 440 million patients globally, using AI to identify, engage and manage stakeholders and participants with the goal of improving study design, enrolment and retention. TrialEngine is described as a clinical trial automation system (CTAS) offering eClinical functionality for administration, patient tracking, data management and reporting during and after trials, using custom AI algorithms and process automation for tasks such as protocol development, study documentation and data extraction.
The company appears in the Entrepreneurs First portfolio directory as R.grid, indicating an association with that company-building program.
Business model
Research Grid supplies software products to organizations running clinical trials, marketed as two named platforms (Inclusive and TrialEngine) that can be adopted individually or together as an end-to-end solution. The sources do not disclose pricing or contract structures.
Traction
The company website reports cumulative figures of 803+ studies, 207+ sponsors and 83+ countries, together with claimed outcomes including a 98.5% enrolment rate across trials, 99.25% patient retention, 73% of enrolled patients belonging to ethnic minorities, 45% cost reduction, 145% patient engagement and 98% faster execution. All figures are self-reported and undated.
▸Full profile — market position, technology, go-to-market, geography, history, risks & controversies
Market position
The company positions itself as offering the only end-to-end AI platform engineered specifically for clinical trials and describes Inclusive as the first all-in-one patient and community engagement, sourcing and management solution of its kind. These are company claims; the sources contain no independent market comparison.
Research Grid differentiates on combining early-stage patient and community sourcing (Inclusive) with in-trial and post-trial operational automation (TrialEngine) in a single traceable platform, claiming coverage of the full trial lifecycle rather than discrete point solutions.
Technology
The company states it operates an AI-native automation engine underpinning both products, applying custom AI algorithms and process automation to clinical trial workflows. It emphasizes traceability across the pre-trial-to-close lifecycle and cites automated generation and handling of protocol development, study documentation and data extraction as core capabilities. Inclusive applies AI to patient and community identification, engagement and management.
Go-to-market
Trial sponsors, pharmaceutical and clinical research organizations, and clinical operations and patient engagement teams. Testimonials on the company site are attributed to individuals at EmVenio, Kayentis, Johnson & Johnson MedTech, Queen Mary University's William Harvey Research Institute, patient community organizations in Indonesia and Lebanon, and an unnamed pharmaceutical simulation supplier.
Geography
Research Grid describes activity spanning 83+ countries and a global patient community network; testimonials reference users and partner organizations in Indonesia, Lebanon and the United Kingdom.
History
Entrepreneurs First lists R.grid among its portfolio companies. The available sources provide no further dated history of the company.
Risks & controversies
All performance and scale figures available come from the company's own website and are unverified and undated; no independent coverage, funding disclosures or financial data appear in the sources.
Compiled by commissioned research from 8 cited public sources — announcements, filings, and press listed under research sources below.
Key figures
latest reportedCompany-reported or press-reported figures, each dated to when it was claimed — not independently audited.
▸Research sources · 8
primary sources listed
- R Gridrgrid.tech · web
8 public sources were cited for this profile; the first-party ones are listed here.
Frequently asked questions
- What does R Grid do?
- Research Grid (R.grid) builds AI-native automation software for clinical trial recruitment and back-office workflows.
- Who founded R Grid?
- R Grid was founded by Amber Hill in 2019.
- Who are R Grid's investors?
- R Grid's investors include Ada Ventures, Entrepreneur First, Fuel Ventures.
- Where is R Grid headquartered?
- R Grid is headquartered in London, GB.